Blood cancer causes different types of blood cells grow uncontrollably, crowding out healthy blood cells and making it harder for the body to fight infections or heal wounds. It falls into these three ...

The i4i PRODICT ® study aims to recruit 1000 people with a prostate (PwP *) aged 40-55 years old, divided into three ethnic backgrounds: (i) Black African and Black African-Caribbean, (ii) South Asian ...

Thousands of patients with a common type of blood cancer could benefit from a new drug combination, while others could see their disease kept at bay for longer. Research published in the journal Blood ...

Melanoma, the most dangerous type of skin cancer, affects around 16,000 people each year. When diagnosed early, it can often be cured. But once the disease has spread to other parts of the body, it ...

Scientists have discovered clues which may explain why some treatments stop working for people with bowel cancer – causing around 16,800 deaths in the UK every year. The study, led by researchers at ...

In this special summer edition of Search, we take an in depth look at the work our scientists are doing in bringing new treatments to people with cancer, who are at the heart of everything we do. You ...

Tazemetostat targets EZH2 – an enzyme that is overexpressed and hyperactive in a number of cancers, including B-cell lymphoma, melanoma and prostate cancer. EZH2 inhibitors on their own have had mixed ...